Your browser doesn't support javascript.
loading
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma.
Wu, Susan Y; Fang, Penny Q; Wang, Ethan B; Ahmed, Sairah; Duvic, Madeleine; Jain, Preetesh; Castillo, Luis E Malpica; Nair, Ranjit; Steiner, Raphael E; Strati, Paolo; Huen, Auris O; Iyer, Swaminathan P; Pinnix, Chelsea C; Dabaja, Bouthaina S; Gunther, Jillian R.
Afiliación
  • Wu SY; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fang PQ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang EB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ahmed S; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Duvic M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jain P; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Castillo LEM; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nair R; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Steiner RE; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Strati P; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huen AO; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Iyer SP; Department of Lymphoma-Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pinnix CC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dabaja BS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gunther JR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Adv Radiat Oncol ; 8(6): 101279, 2023.
Article en En | MEDLINE | ID: mdl-37448588

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Adv Radiat Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Adv Radiat Oncol Año: 2023 Tipo del documento: Article